Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
about
Role of biologics in severe eosinophilic asthma - focus on reslizumabEfficacy and Safety of Anti-Interleukin-5 Therapy in Patients with Asthma: A Systematic Review and Meta-Analysis.Human Bronchial Epithelial Cell-Derived Factors from Severe Asthmatic Subjects Stimulate Eosinophil Differentiation.The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.Toll-like receptor-induced expression of epithelial cytokine receptors on haemopoietic progenitors is altered in allergic asthma.Asthma exacerbations: factors related to longer hospital stay.The emerging role of transient receptor potential channels in chronic lung disease.Bioinnovation Enterprise: An engine driving breakthrough therapies.Translating Asthma: Dissecting the Role of Metabolomics, Genomics and Personalized Medicine.Efficacy and safety of benralizumab for eosinophilic asthma: A systematic review and meta-analysis of randomized controlled trials.Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials.Enhanced design of inhaled therapeutics: what does the future hold?Use of clinical characteristics to predict spirometric classification of obstructive lung disease.The importance of allergic disease in public health: an iCAALL statement.
P2860
Q26738503-D59EA98F-9F7D-4E34-97E9-1B78E740D0FCQ36201117-F9CB7F1A-311D-4545-8FA0-6A1F460CBD39Q38602337-EE1E9B59-70DC-47EF-9947-DB0056798AEAQ38704374-0602EB37-E2C1-43C4-9525-8340076E528DQ38817408-C2CEE2AB-B90C-49C5-A6BF-B225DE8D2D13Q38923185-535ECB3F-248E-472F-9BD9-FBE12A4DCC41Q38933878-B23360B3-B9A4-46F1-9E68-FCED7FBE1D03Q39154827-FD093751-7807-431F-AA3E-CC25C517AD77Q41355467-31699186-23FD-4E7E-A15C-5C7BB8468928Q42130361-DF3EF57B-60F3-480B-BEA1-A61D1C680781Q47353500-A5C46893-69BB-449C-8E17-9DFC30598AD1Q47358068-73A41679-AB26-4C00-A522-8C70A05F4B3BQ47686042-492CB836-4EBC-4680-BBF3-20AD3A125253Q48209139-A4AE852B-0227-4C0F-BDD6-7963CD7278CBQ55277147-FA100FC0-0048-46AE-8194-C78328A9E81FQ55361814-E4276FB2-0A7A-4ECF-9947-993F936728CE
P2860
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
@en
type
label
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
@en
prefLabel
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
@en
P356
P1476
Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma
@en
P2093
A I El-Gammal
P356
10.1002/CPT.284
P407
P577
2015-11-18T00:00:00Z